BRAFv600E mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma

被引:8
|
作者
Jing Fan-jing [1 ]
Liang Jun [1 ]
Liang Zhi-yong [2 ]
Meng Chao [1 ]
Long Wen [3 ]
Li Xiao-yi [4 ]
Lin Yan-song [3 ]
机构
[1] Qingdao Univ, Qingdao Med Coll, Affiliated Hosp, Dept Oncol, Qingdao 266003, Shandong, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China
[3] Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China
[4] Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
papillary thyroid carcinoma; B-RAF; neoplasm metastasis; vascular endothelial growth factor; BRAF MUTATION; CLINICAL-IMPLICATIONS; PROGNOSTIC-FACTORS; CANCER; SURVIVAL; OUTCOMES; EPIDEMIOLOGY; VEGF;
D O I
10.3760/cma.j.issn.0366-6999.20122032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background BRAF(v600E) mutation is correlated with local aggressive clinicopathological features in papillary thyroid carcinoma; yet the relationship between this genetic variation and distant papillary thyroid carcinoma metastasis was unclear. This study aimed to investigate whether BRAF(v600E) is predictive for distant metastasis in the Chinese population. Methods One hundred and seven patients with papillary thyroid carcinoma were enrolled in this study, including 43 patients with distant metastasis and 64 patients without. Quantitative real-time polymerase chain reaction was used to detect BRAF(v600E) mutation, while immunohistochemistry was performed to detect vascular endothelial growth factor (VEGF) expression. The associations between distant metastasis and BRAF(v600E) mutation, and VEGF expression as well as local clinicopathological factors were determined. Results A total of 28.6% of the patients in the distant metastasis group harbored BRAF(v600E) mutation, which was significantly lower than in the without distant metastasis group (68.8%, P < 0.001). BRAF(v600E) mutation was negatively correlated with positive VEGF expression (P=0.001). Furthermore, 52.2% of the patients with distant metastasis exhibited VEGF expression, compared with 25.0% of those without. Higher levels of VEGF expression were also observed in the distant metastasis group. Tumor size, extra-thyroid invasion, and BRAF(v600E) mutation were independent predictors for distant metastasis according to multivariate analysis (odds ratios were 2.8, 12.4, and 0.3; 95% C/ 1.483-5.334, and 2.950-52.407, 0.100-0.890; P=0.002, 0.001, and 0.030, respectively). BRAF(v600E) mutation was negatively correlated with distant metastasis in adult subgroup analysis (P=0.005) but was not an independent parameter. Conclusions BRAF(v600E) mutation is predictive for distant metastasis in papillary thyroid carcinoma but not positively. VEGF may be involved in the pathogenesis of distant metastasis.
引用
下载
收藏
页码:3013 / 3018
页数:6
相关论文
共 50 条
  • [21] BRAFV600E Mutation and Papillary Thyroid Cancer: Chicken or Egg?
    Xing, Mingzhao
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (07): : 2295 - 2298
  • [22] Papillary Thyroid Microcarcinoma: Clinicopathological Correlation with BRAFV600E Mutation
    Virk, R. K.
    Finkelstein, A.
    Prasad, A.
    Hui, P.
    Carling, T.
    Roman, S. A.
    Sosa, J. A.
    Udelsman, R.
    Prasad, M.
    LABORATORY INVESTIGATION, 2012, 92 : 151A - 151A
  • [23] Papillary Thyroid Microcarcinoma: Clinicopathological Correlation with BRAFV600E Mutation
    Virk, R. K.
    Finkelstein, A.
    Prasad, A.
    Hui, P.
    Carling, T.
    Roman, S. A.
    Sosa, J. A.
    Udelsman, R.
    Prasad, M.
    MODERN PATHOLOGY, 2012, 25 : 151A - 151A
  • [24] The synergic effect of BRAFV600E mutation and multifocality on central lymph node metastasis in unilateral papillary thyroid carcinoma
    Qu, Hai-Jiang
    Qu, Xue-Yan
    Hu, Ze
    Lin, Yan
    Wang, Jun-Rong
    Zheng, Chang-Fu
    Tan, Zhuo
    ENDOCRINE JOURNAL, 2018, 65 (01) : 113 - 120
  • [25] Predicting factors of central lymph node metastasis and BRAFV600E mutation in Chinese population with papillary thyroid carcinoma
    Sheng Li Zhou
    Yan Ping Guo
    Lei Zhang
    Tao Deng
    Zi Guang Xu
    Chao Ding
    Wen Cong Sun
    Yue Wu Zhao
    Ling Fei Kong
    World Journal of Surgical Oncology, 19
  • [26] Predicting factors of central lymph node metastasis and BRAFV600E mutation in Chinese population with papillary thyroid carcinoma
    Zhou, Sheng Li
    Guo, Yan Ping
    Zhang, Lei
    Deng, Tao
    Xu, Zi Guang
    Ding, Chao
    Sun, Wen Cong
    Zhao, Yue Wu
    Kong, Ling Fei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [27] Correlation between BRAFV600E mutation and clinicopathological features in pediatric papillary thyroid carcinoma
    Jiangqiao Geng
    Huanmin Wang
    Yuanhu Liu
    Jun Tai
    Yaqiong Jin
    Jie Zhang
    Lejian He
    Libing Fu
    Hong Qin
    Yingluan Song
    Jinzhu Su
    Aiying Zhang
    Xin Wen
    Yongli Guo
    Xin Ni
    Science China Life Sciences, 2017, 60 (07) : 729 - 738
  • [28] Accuracy and Reproducibility of Histologic Features Predictive of BRAFV600E Mutation in Papillary Thyroid Carcinoma
    Virk, R. K.
    Finkelstein, A.
    Prasad, A.
    Hui, P.
    Chhieng, D.
    Theoharis, C.
    Gibson, J.
    Roman, S.
    Prasad, M.
    MODERN PATHOLOGY, 2012, 25 : 150A - 151A
  • [29] Correlation between BRAFV600E mutation and clinicopathological features in pediatric papillary thyroid carcinoma
    Jiangqiao Geng
    Huanmin Wang
    Yuanhu Liu
    Jun Tai
    Yaqiong Jin
    Jie Zhang
    Lejian He
    Libing Fu
    Hong Qin
    Yingluan Song
    Jinzhu Su
    Aiying Zhang
    Xin Wen
    Yongli Guo
    Xin Ni
    Science China Life Sciences, 2017, 60 : 729 - 738
  • [30] BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic
    Sykorova, V.
    Dvorakova, S.
    Ryska, A.
    Vcelak, J.
    Vaclavikova, E.
    Laco, J.
    Kodetova, D.
    Kodet, R.
    Cibula, A.
    Duskova, J.
    Hlobilkova, A.
    Astl, J.
    Vesely, D.
    Betka, J.
    Hoch, J.
    Smutny, S.
    Cap, J.
    Vlcek, P.
    Novak, Z.
    Bendlova, B.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2010, 33 (05) : 318 - 324